AKT1 and hepatocellular carcinoma: Likewise, a prior study focusing on hepatocellular carcinoma revealed that activating the AKT/mTOR pathway was able to raise SREBP‐1 expression levels, thereby restructuring hepatic lipid metabolism [43].